SlideShare a Scribd company logo
1 of 4
Download to read offline
Parkinson’s Disease Therapeutics Market to 2019 – Pipeline
Shows Shift towards Long Term Disease Management

by
GBI Research

Explore all reports for “Parkinson Disease Drugs”
market @
http://www.rnrmarketresearch.com/reports/lifesciences/pharmaceuticals/diseases-treatment/parkinsondisease-drugs.
© RnRMarketResearch.com ;
sales@rnrmarketresearch.com ;
+1 888 391 5441
Parkinson’s Disease Therapeutics Market to 2019 –
Pipeline Shows Shift towards Long Term Disease
Management
The collection of ‘Parkinson Disease Drugs’ market research reports has a new
addition of “Parkinson’s Disease Therapeutics Market to 2019 – Pipeline Shows
Shift towards Long Term Disease Management” on RnRMarketResearch.com .
The Latest pharma report – “Parkinson’s Disease Therapeutics Market to 2019 –
Pipeline Shows Shift towards Long Term Disease Management”. The Parkinson’s
disease (PD) market is dominated by symptomatic treatments targeting
functional impairment in PD. Levodopa has remained the gold standard
treatment for almost 40 years and has significantly improved patient quality of
life. There is currently there is a huge unmet need for disease-modifying
treatments that slow progression or have neuroprotective properties. Over the
2012–2019 forecast periods, the PD market is anticipated to decline from $3.4
billion in 2012 to $2.9 billion in 2019, as a consequence of upcoming patent
expirations of high-profile products such as Azilect, Stalevo and Comtan.
Although a few market entrants are anticipated to enter the market over the
forecast period, they are not expected to offset the impact of generic erosion.
Request a sample copy of this report @

http://www.rnrmarketresearch.com/contacts/request-sample?rname=136892.
© RnRMarketResearch.com ;
sales@rnrmarketresearch.com ;
+1 888 391 5441
Parkinson’s Disease Therapeutics Market to 2019
– Pipeline Shows Shift towards Long Term Disease
Management
Despite their superior profiles over existing treatments, these new products are
not expected to command a premium price as they will be competing against
generic products. The current PD pipeline reflects a shift of focus to long-term
PD management, marked by the development of key pipeline candidates
targeting levodopa-associated motor complications. These products will have
the potential to change the future treatment algorithm as side effects of
dopaminergic therapies become more manageable.
Scope
A brief introduction to PD, including pathogenesis, disease staging, diagnosis
and treatment algorithms
In-depth analysis of the drugs available for the treatment of PD, covering their
safety, efficacy, treatment patterns, and strengths/weaknesses, as well as a heat
map comparing drugs in terms of safety and efficacy

Complete report available @
http://www.rnrmarketresearch.com/parkinsons-disease-therapeutics-marketto-2019-pipeline-shows-shift-towards-long-term-disease-management-marketreport.html.
© RnRMarketResearch.com ;
sales@rnrmarketresearch.com ;
+1 888 391 5441
Parkinson’s Disease Therapeutics Market to
2019 – Pipeline Shows Shift towards Long
Term Disease Management
For more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com /
+18883915441

RnR Market Research
RnRMarketResearch.com, an online repository of market research reports, offers in-depth
analysis of over 5000 market segments. RnR Market Research library has syndicated reports by
leading market research publishers across the globe.

© RnRMarketResearch.com ;
sales@rnrmarketresearch.com ;
+1 888 391 5441

More Related Content

Viewers also liked

ANESTHESIA MANAGEMENT OF PATIENTS WITH COEXISTING AND ENDOCRINE DISEASES
ANESTHESIA MANAGEMENT OF PATIENTS WITH COEXISTING AND ENDOCRINE DISEASESANESTHESIA MANAGEMENT OF PATIENTS WITH COEXISTING AND ENDOCRINE DISEASES
ANESTHESIA MANAGEMENT OF PATIENTS WITH COEXISTING AND ENDOCRINE DISEASESnurhussien rizke
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s diseaseJijo G John
 
Parkinsons Disease
Parkinsons DiseaseParkinsons Disease
Parkinsons Disease000 07
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Diseasemarlasavage
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Diseaseguest27ee33
 

Viewers also liked (8)

Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
 
ANESTHESIA MANAGEMENT OF PATIENTS WITH COEXISTING AND ENDOCRINE DISEASES
ANESTHESIA MANAGEMENT OF PATIENTS WITH COEXISTING AND ENDOCRINE DISEASESANESTHESIA MANAGEMENT OF PATIENTS WITH COEXISTING AND ENDOCRINE DISEASES
ANESTHESIA MANAGEMENT OF PATIENTS WITH COEXISTING AND ENDOCRINE DISEASES
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s disease
 
Parkinsons Disease
Parkinsons DiseaseParkinsons Disease
Parkinsons Disease
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Disease
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Disease
 
Parkinson s disease
Parkinson s diseaseParkinson s disease
Parkinson s disease
 
Parkinson's Disease
Parkinson's DiseaseParkinson's Disease
Parkinson's Disease
 

Recently uploaded

blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 

Recently uploaded (20)

blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 

2019 Parkinson’s Disease Therapeutics Industry - Latest Report

  • 1. Parkinson’s Disease Therapeutics Market to 2019 – Pipeline Shows Shift towards Long Term Disease Management by GBI Research Explore all reports for “Parkinson Disease Drugs” market @ http://www.rnrmarketresearch.com/reports/lifesciences/pharmaceuticals/diseases-treatment/parkinsondisease-drugs. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441
  • 2. Parkinson’s Disease Therapeutics Market to 2019 – Pipeline Shows Shift towards Long Term Disease Management The collection of ‘Parkinson Disease Drugs’ market research reports has a new addition of “Parkinson’s Disease Therapeutics Market to 2019 – Pipeline Shows Shift towards Long Term Disease Management” on RnRMarketResearch.com . The Latest pharma report – “Parkinson’s Disease Therapeutics Market to 2019 – Pipeline Shows Shift towards Long Term Disease Management”. The Parkinson’s disease (PD) market is dominated by symptomatic treatments targeting functional impairment in PD. Levodopa has remained the gold standard treatment for almost 40 years and has significantly improved patient quality of life. There is currently there is a huge unmet need for disease-modifying treatments that slow progression or have neuroprotective properties. Over the 2012–2019 forecast periods, the PD market is anticipated to decline from $3.4 billion in 2012 to $2.9 billion in 2019, as a consequence of upcoming patent expirations of high-profile products such as Azilect, Stalevo and Comtan. Although a few market entrants are anticipated to enter the market over the forecast period, they are not expected to offset the impact of generic erosion. Request a sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=136892. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441
  • 3. Parkinson’s Disease Therapeutics Market to 2019 – Pipeline Shows Shift towards Long Term Disease Management Despite their superior profiles over existing treatments, these new products are not expected to command a premium price as they will be competing against generic products. The current PD pipeline reflects a shift of focus to long-term PD management, marked by the development of key pipeline candidates targeting levodopa-associated motor complications. These products will have the potential to change the future treatment algorithm as side effects of dopaminergic therapies become more manageable. Scope A brief introduction to PD, including pathogenesis, disease staging, diagnosis and treatment algorithms In-depth analysis of the drugs available for the treatment of PD, covering their safety, efficacy, treatment patterns, and strengths/weaknesses, as well as a heat map comparing drugs in terms of safety and efficacy Complete report available @ http://www.rnrmarketresearch.com/parkinsons-disease-therapeutics-marketto-2019-pipeline-shows-shift-towards-long-term-disease-management-marketreport.html. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441
  • 4. Parkinson’s Disease Therapeutics Market to 2019 – Pipeline Shows Shift towards Long Term Disease Management For more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441 RnR Market Research RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnR Market Research library has syndicated reports by leading market research publishers across the globe. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441